Blog - Page 2 of 3 - Humane Genomics

Presenting at AACR

April 10, 2023 pete 0 Comment

We are excited to announce we are presenting at the AACR annual meeting for the first time. AACR is the American Association for Cancer Research and its meeting is the largest in the world of cancer research. Last year, over 20,000 scientists, clinicians and other health care professionals, and survivors and patient advocates from around the world traveled to New Orleans. The AACR meeting for 2023 is held in Orange County Convention Center, Orlando, Florida and we have been invited…

Introduction – Brenda

March 9, 2023 pete 0 Comment

Q: Tell me a bit about yourself Hello! My name is Brenda and I grew up in Montgomery County Maryland. I spent a lot of my weekends visiting DC going to museums and visiting monuments nearby. The National Museum of Natural History is where I first fell in love with research and it helped shape a lot of my interests and career path. The exhibits and stories they told sparked my curiosity for science and discovery. When I visit home…

Rational Design of Oncolytic Viruses

February 23, 2023 pete 0 Comment

In this post we give an overview of the history of using viruses as potential treatment for cancer. We also outline the challenges a great viral therapy needs to overcome. Last, we review our approach to rationally design and engineer safe and effective oncolytic viruses. History and current state Since the middle of the last century there has been anecdotal evidence that virus infections can help in curing or slowing down cancer. Unfortunately these infections happened randomly and the results…

Our platform

December 16, 2022 pete 0 Comment

In this post, I would like to introduce the Humane Genomics Artificial Virus Platform. Why develop an artificial virus platform? For decades, a lot of research has been conducted to see if natural viruses can be used as cancer therapeutics, with limited success. Over the last 10 years, the technology to engineer, to build viruses specifically as cancer therapeutics has matured. However, most technology approaches to make these viruses are complicated, error prone, time consuming and expensive. To address these…

Introduction – Rupsa

November 18, 2022 pete 0 Comment

Q: Tell me a bit about yourself. My name is Rupsa Basu and I am a viral immunologist by passion and a backpacker at heart. My mantra of life is to dream, believe and achieve. As a seven years old kid, I started dreaming about becoming a scientist and developed an increased interest in reading science fiction and detective fiction stories. After reading the book “Selfish Gene” in elementary school, I got inspired with nature’s scientific secrets and slowly idolized…

Year in review 2020

January 23, 2021 pete 0 Comment

Looking back, 2020 was quite the year. We designed 200 unique oncolytic viruses, and we confirmed 163 viruses are working (replication competent) in the lab. Among these, we engineered 42 glycoproteins, 29 promoters and 14 therapeutic genes. We generated more than 10 billion virus particles over the year, which we tested in 11 research cell lines and 8 patient derived cells. Building on our in vitro success, we also conducted 2 mouse studies. How did the year unfold chronologically?…

Introduction – Taylor

January 10, 2021 pete 1 comment

Q: Tell me a bit about yourself. My name is Taylor Flaat and I am from Panama City Beach, Florida, although I was actually born in Grand Forks, North Dakota. We moved from Grand Forks when I was just two years old and my family has been in Panama City ever since. I grew up an avid fisherman and baseball player, with my favorite food definitely being the homestyle cooking of my mom and grandma! I did my undergraduate degree…

Last update on our COVID-19 vaccine

December 18, 2020 pete 0 Comment

It has been almost 7 months since the last update of our work on the COVID-19 vaccine candidate. In this post, we share the results and what we have learned. Because there are several other vaccines available that are highly effective against SARS-CoV-2, we decided to stop further research on our vaccine and to focus on developing cancer therapies. We will explain more about our decision in this post. First, a brief reminder on why we decided to make a…

Update on COVID19 vaccine

May 5, 2020 pete 5 comments

We want to share exciting news: Lab results show that we have made our vaccine as designed. In our previous post, we disclosed a design of a potential vaccine for COVID-19 based on VSV. In a subsequent post, we have also shared quite a bit of scientific background on why we believe it should work. With this post, we want to share an update on our work in the lab. Before we do that a bit of background. The physical…

Scientific Data Supporting Our Proposal For COVID-19 Vaccine

March 17, 2020 Chad Moles 0 Comment

With a lot of countries taking more drastic measures and enforcing limited social contact (known as social distancing), we are left to ask, what is next? We believe it is possible to make a vaccine for COVID-19 that provides long lasting immunity. We also believe we can do this, fast. We recently shared our design here. Since then, we have found several papers that support our line of thinking. Included among these, an article by Liniger et al. that describes…